• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙视网膜蛋白低表达和中性粒细胞与淋巴细胞比值高是行胸膜外全肺切除术的恶性间皮瘤患者的不良预后因素。

Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.

机构信息

Asbestos Diseases Research Institute, Bernie Banton Centre, Sydney, Australia.

出版信息

J Thorac Oncol. 2011 Nov;6(11):1923-9. doi: 10.1097/JTO.0b013e31822a3740.

DOI:10.1097/JTO.0b013e31822a3740
PMID:22011651
Abstract

INTRODUCTION

Survival after extrapleural pneumonectomy (EPP) is variable in patients with malignant pleural mesothelioma (MPM), and there are no validated prognostic factors that could be used preoperatively. We investigated the calretinin and D2-40 expression and the neutrophil-to-lymphocyte ratio (NLR), an index of systemic inflammation as potential preoperative prognostic factors.

METHODS

Consecutive patients who underwent EPP were included in this retrospective study. Potential prognostic factors such as age, gender, histological subtype, baseline laboratory parameters including NLR, and immunohistochemical staining for calretinin and D2-40 were evaluated. Overall survival (OS) from the date of surgery was determined by the Kaplan-Meier method. The prognostic value of the variables was examined using Cox regression, and significant factors (p < 0.05) were entered into a multivariate model to determine their independent effect.

RESULTS

A total of 85 patients were included: median age 58 years; 80% men; 77% epithelial and 23% biphasic MPM. The median OS was 19.7 months. The following variables were predictive of longer OS: female gender (p = 0.02), epithelial subtype (p = 0.04), low NLR (p < 0.01), and high calretinin score (p < 0.001). In a multivariate analysis, only NLR ≥3 (hazard ratio 1.79; 95% confidence interval: 1.04-3.07; p = 0.04) and calretinin score ≤33 versus more than 67% (hazard ratio 4.72; 95% confidence interval: 1.97-11.32; p < 0.01) remained independent predictors. The addition of calretinin score increased the explained variation by 10.1%.

CONCLUSIONS

Both low calretinin expression and high NLR were independently associated with poor prognosis in patients with MPM undergoing EPP, and the calretinin score seemed to improve the accuracy of the prognostic model.

摘要

简介

恶性胸膜间皮瘤(MPM)患者行胸膜外全肺切除术(EPP)后的生存率各不相同,目前尚无可用于术前的验证性预后因素。我们研究钙卫蛋白和 D2-40 的表达以及中性粒细胞与淋巴细胞比值(NLR),作为全身炎症的指标,作为潜在的术前预后因素。

方法

本回顾性研究纳入了连续接受 EPP 的患者。评估了可能的预后因素,如年龄、性别、组织学亚型、包括 NLR 在内的基线实验室参数,以及钙卫蛋白和 D2-40 的免疫组织化学染色。从手术日期开始确定总生存(OS)。使用 Kaplan-Meier 法检查变量的预后价值。使用 Cox 回归检查显著因素(p<0.05),并将显著因素纳入多变量模型以确定其独立影响。

结果

共纳入 85 例患者:中位年龄 58 岁;80%为男性;77%上皮型,23%双相型 MPM。中位 OS 为 19.7 个月。以下变量与更长的 OS 相关:女性(p=0.02)、上皮型(p=0.04)、低 NLR(p<0.01)和高钙卫蛋白评分(p<0.001)。多变量分析中,仅 NLR≥3(风险比 1.79;95%置信区间:1.04-3.07;p=0.04)和钙卫蛋白评分≤33 与大于 67%(风险比 4.72;95%置信区间:1.97-11.32;p<0.01)是独立的预测因素。钙卫蛋白评分的加入增加了 10.1%的可解释变异。

结论

低钙卫蛋白表达和高 NLR 均与接受 EPP 的 MPM 患者预后不良独立相关,且钙卫蛋白评分似乎提高了预后模型的准确性。

相似文献

1
Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.钙视网膜蛋白低表达和中性粒细胞与淋巴细胞比值高是行胸膜外全肺切除术的恶性间皮瘤患者的不良预后因素。
J Thorac Oncol. 2011 Nov;6(11):1923-9. doi: 10.1097/JTO.0b013e31822a3740.
2
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales.新南威尔士州大量恶性胸膜间皮瘤患者生存相关因素
Br J Cancer. 2014 Oct 28;111(9):1860-9. doi: 10.1038/bjc.2014.478. Epub 2014 Sep 4.
3
Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board.恶性胸膜间皮瘤预后因素的验证:新南威尔士尘埃疾病委员会寻求赔偿的患者数据的回顾性分析。
Clin Lung Cancer. 2013 Jan;14(1):70-7. doi: 10.1016/j.cllc.2012.03.011. Epub 2012 Jun 1.
4
The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.隐匿性疾病在恶性间皮瘤胸膜外肺切除术后切缘和淋巴结中的价值。
Ann Thorac Surg. 2008 May;85(5):1740-6. doi: 10.1016/j.athoracsur.2008.01.088.
5
Inflammation-based prognostic indices in malignant pleural mesothelioma.基于炎症的恶性胸膜间皮瘤预后指标。
J Thorac Oncol. 2012 Mar;7(3):587-94. doi: 10.1097/JTO.0b013e31823f45c1.
6
Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis.恶性胸膜间皮瘤术后长期生存的预后评分:一项多中心分析
Ann Thorac Surg. 2015 Sep;100(3):890-7. doi: 10.1016/j.athoracsur.2015.04.087. Epub 2015 Jul 9.
7
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.胸膜外肺切除术与胸膜剥脱术/纤维板剥脱术治疗恶性胸膜间皮瘤的手术疗效:663例患者的结果
J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3. doi: 10.1016/j.jtcvs.2007.10.054. Epub 2008 Feb 14.
8
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.接受胸膜外全肺切除术的恶性胸膜间皮瘤患者 3 年生存的临床和病理特征。
Eur J Cardiothorac Surg. 2011 Aug;40(2):298-303. doi: 10.1016/j.ejcts.2010.12.024. Epub 2011 Feb 9.
9
Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.恶性胸膜间皮瘤胸膜外肺切除术后患者的分期——机构回顾与当前进展
Interact Cardiovasc Thorac Surg. 2011 May;12(5):754-7. doi: 10.1510/icvts.2010.262972. Epub 2011 Feb 8.
10
Expression of Wilms' tumor gene (WT1) is associated with survival in malignant pleural mesothelioma.肾母细胞瘤基因(WT1)的表达与恶性胸膜间皮瘤的生存率相关。
Clin Transl Oncol. 2014 Sep;16(9):776-82. doi: 10.1007/s12094-013-1146-6. Epub 2013 Dec 10.

引用本文的文献

1
A Promising Prognostic Indicator for Pleural Mesothelioma: Pan-Immuno-Inflammation Value.一种有前景的胸膜间皮瘤预后指标:全免疫炎症值。
J Clin Med. 2025 Aug 4;14(15):5467. doi: 10.3390/jcm14155467.
2
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.间皮瘤全身炎症评分与总生存期独立相关,并可预测胸膜间皮瘤多模式治疗的获益情况。
Cancers (Basel). 2025 Apr 20;17(8):1371. doi: 10.3390/cancers17081371.
3
Myeloid Cell Mobilization and Recruitment by Human Mesothelioma in NSG-SGM3 Mice.
人恶性间皮瘤在NSG-SGM3小鼠中引起的髓样细胞动员与募集
Cells. 2024 Dec 23;13(24):2135. doi: 10.3390/cells13242135.
4
BAP1, Wilms' tumor 1, and calretinin in predicting survival and response to first-line chemotherapy in patients with pleural mesothelioma.BAP1、肾母细胞瘤蛋白1和钙视网膜蛋白在预测胸膜间皮瘤患者的生存率及一线化疗反应中的作用
J Cancer Res Clin Oncol. 2024 Jan 27;150(2):38. doi: 10.1007/s00432-023-05565-6.
5
Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma.血清钙网蛋白和遗传变异性作为恶性间皮瘤的预后和预测因素。
Int J Mol Sci. 2023 Dec 22;25(1):190. doi: 10.3390/ijms25010190.
6
Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis.术前中性粒细胞与淋巴细胞比值与恶性胸膜间皮瘤患者免疫细胞中的 PD-L1 表达相关,并可预测预后。
Sci Rep. 2023 Mar 31;13(1):5263. doi: 10.1038/s41598-023-31448-4.
7
Pleural Mesothelioma: A Rapid Evolution of an Indolent Disease.胸膜间皮瘤:一种惰性疾病的快速演变
Cureus. 2023 Jan 19;15(1):e33965. doi: 10.7759/cureus.33965. eCollection 2023 Jan.
8
Prospective validation and extension of the Multimodality Prognostic Score for the treatment allocation of pleural mesothelioma patients.前瞻性验证和扩展多模态预后评分在间皮瘤患者治疗分配中的应用。
Eur J Cardiothorac Surg. 2022 Jul 11;62(2). doi: 10.1093/ejcts/ezac085.
9
Epidemiology and Clinical Aspects of Malignant Pleural Mesothelioma.恶性胸膜间皮瘤的流行病学与临床特征
Cancers (Basel). 2021 Aug 20;13(16):4194. doi: 10.3390/cancers13164194.
10
Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma.间皮瘤风险评分:一种用于恶性胸膜间皮瘤的新的预后预处理、临床-分子算法。
J Thorac Oncol. 2021 Nov;16(11):1925-1935. doi: 10.1016/j.jtho.2021.06.014. Epub 2021 Jul 6.